Our results show that in addition to a reduction in differentiation capability caused by driver mutations CML progression can also be explained by the features of the hematopoietic hierarchy even in the case when only the BCR::ABL1 clone is present. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.